Loading...
Access to new cancer medicines in Australia: dispelling the myths and informing a public debate
Despite the high level of spending on cancer medicines in Australia, consumer organisations and the pharmaceutical industry often make claims of delayed or lack of access to new cancer medicines—claims that are frequently supported by prominent coverage in the Australian media. These claims, while m...
Na minha lista:
| Udgivet i: | J Pharm Policy Pract |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4823878/ https://ncbi.nlm.nih.gov/pubmed/27057313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-016-0062-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|